For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk population, ...

Objective To determine the adverse outcomes following resumption of anticoagulation in patients with anticoagulation-associated intracranial haemorrhage (ICH). Design We performed a systematic review ...

Aspirin is another kind of NSAID, but a 2015 Cochrane Review of evidence found that it's less effective than ibuprofen and paracetamol, and more likely to cause adverse side effects. It’s best to take ...

Rates of oral anticoagulation (OAC) nonprescription in atrial fibrillation approach 50%. Understanding reasons for OAC nonprescription may reduce gaps in guideline‐recommended care. We aimed to ...

Continued anticoagulation is recommended for patients with active cancer and/or ongoing cancer treatment. Extended treatment with low-dose apixaban was noninferior to a full dose for preventing ...

Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim: To ...

Extended anticoagulant therapy with a reduced-dose of apixaban was noninferior to extended therapy with a full-dose of apixaban in preventing recurrent venous thromboembolism (VTE) in patients with ...

Paracetamol, aspirin and ibuprofen are among the most widely used. While they are all effective for pain relief, they each work in a slightly different way and ideally, tackling different symptoms.

or concomitant use of aspirin, corticosteroids or anticoagulants). This stratification is based on the MUCOSA trial, [11] in which the annual incidence of NSAID-induced ulcer complications was 0.8 ...

Patients with spontaneous coronary artery dissection (SCAD) who are discharged on oral anticoagulation (OAC) or dual antiplatelet therapy (DAPT) that combines aspirin plus ticagrelor have a higher ...